RTW INVESTMENTS LP 13D/13G Filings for Arrowhead Pharmaceuticals, Inc. (ARWR)

RTW INVESTMENTS LP 13D and 13G filings for Arrowhead Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-02-14
1:43 pm
Sale
2019-12-3113GArrowhead Pharmaceuticals, Inc.
ARWR
RTW INVESTMENTS LP0
0.000%
-5,316,156decrease
(Position Closed)
Filing